The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
A Survey of Practices in the United States Regarding Hepatitis C Screening in Pregnant Women
Clin Ther. 2021 Feb 5;S0149-2918(21)00020-5. doi: 10.1016/j.clinthera.2021.01.016.Online ahead of print.
Elizabeth A Godar1, Ravi Jhaveri2
Author information
1Division of Infectious Diseases, Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
2Division of Infectious Diseases, Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ravi.jhaveri@northwestern.edu.
Abstract
Purpose: Hepatitis C virus (HCV) cases have increased in the past decade, with many cases in pregnant patients. However, recommendations for HCV screening during pregnancy vary by professional organization.
Methods: Prenatal care providers were surveyed via e-mail about factors affecting choice of HCV screening.
Findings: A total of 86 completed surveys were received. Providers using risk-based screening valued guidance from obstetrics and gynecology societies and risk for vertical transmission. Providers using universal screening valued availability of curative treatment in addition to guidance from the Centers for Disease Control and Prevention/infectious diseases societies and obstetrics and gynecology societies.
Implications: The results highlight the need for consensus guidelines on HCV screening as a part of prenatal care.